Beverages
Coffee's evidence has solidified in its favor; alcohol's J-curve has collapsed; tea sits between them with a smaller but consistent positive signal. And the unsexy one — water — turns out to matter more than people thought, both for biological aging and for what's actually in the bottle.
Four beverages dominate the longevity conversation: water, coffee, tea, and alcohol. The evidence on each has shifted notably in the last decade.
Water is no longer "drink eight glasses" folklore — chronic mild dehydration tracks with faster biological aging, and PFAS / microplastic contamination of municipal and bottled supplies has made filtration choices a real longevity decision. Coffee has accumulated a remarkably consistent positive signal across major outcomes. Tea shows smaller, less rigorously studied benefits in the same general direction. Alcohol's historical "J-curve" cardio-protection has largely collapsed under Mendelian randomization scrutiny.
What the evidence actually supports
Water — Moderate to Strong (and underrated):
- Serum sodium chronically >142 mmol/L (driven by low water intake) tracks with up to 50% higher odds of being biologically older than chronological age and HR ~1.39 for chronic disease over 25 years (ARIC, n=15,752). >144 mmol/L: HR 1.21 for premature mortality.
- A 2024 JAMA Network Open systematic review of 18 RCTs found replicated benefit for weight management, kidney stones, migraine prophylaxis, recurrent UTIs, and orthostatic vertigo.
- Sip metered, don't chug — bolus drinking captures only ~55% of the fluid; metered captures ~75%.
- PFAS and microplastics make filtration a real choice. Reverse osmosis with remineralization is the protocol of choice for most modern municipal supplies.
- Functional waters: hydrogen water has plausible biology and preliminary RCTs; alkaline, "structured," and marine-plasma waters do not.
Coffee — Moderate to Strong:
- 2–4 cups/day associates with lowest all-cause mortality (HR ~0.83–0.85) across multiple large cohorts.
- Reduced risk of type 2 diabetes (~6% per cup/day), Parkinson's disease, liver disease, several cancers.
- Both caffeinated and decaffeinated show benefit, suggesting non-caffeine constituents (chlorogenic acids, polyphenols) contribute.
- Mendelian randomization is less consistent than observational data — residual confounding by lifestyle remains a possibility.
- EFSA / FDA: up to 400 mg caffeine/day is safe for healthy adults; 200 mg/day in pregnancy.
Tea — Modest:
- 1–2 cups/day of tea associated with 18% lower dementia risk in the 2026 JAMA NHS/HPFS analysis (n=131,821).
- Modest mortality and cardiovascular signals; black tea benefits plateau around 2 cups/day, green tea closer to linear up to 3–4 cups/day.
- Stronger non-heme iron absorption inhibition than coffee (matters for those with marginal iron status).
- Bone-mineral density signal is mildly positive in older adults.
- Effect sizes smaller than coffee's; safety profile is excellent (avoid concentrated green tea extract supplements — rare hepatotoxicity).
Alcohol — the J-curve has collapsed:
- WHO January 2023: "no level of alcohol consumption is safe for health."
- Mendelian randomization studies (Millwood 2019 Lancet, multiple since) find monotonic harm — no protective threshold.
- Cancer risk begins from the first drop and rises linearly; alcohol is a Group 1 carcinogen.
- Acetaldehyde is the proximate carcinogen. ALDH2*2 East Asian variants confirm causality.
- Some cardiovascular signals remain contested (NASEM 2025 still found moderate-vs-abstainer benefit in studies excluding former drinkers), but the net effect even at moderate doses is unfavorable.
Practical beverage guidance
- Coffee, 2–4 cups/day filtered is well-supported. Watch evening timing (caffeine half-life 5–6 h).
- Avoid added sugar in coffee. Black, with milk, or with cinnamon — fine. Sugary coffee drinks cancel most of the benefit.
- For alcohol, the minimum-risk dose is at or near zero. Specifically:
- Cancer risk (especially breast, oral, esophageal, colorectal) begins from the first drop.
- Don't start drinking for "heart benefits" — those benefits don't survive rigorous methods.
- If you currently drink, less is better. Canada's 2023 guidance suggests <2 drinks/week as the lower-risk threshold.
- Drink water steadily, not in boluses. ~2.0–3.0 L/day total fluids for most healthy adults; pale-yellow urine and rare thirst are the real biomarkers. Filter for PFAS and microplastics. See Water.
- Tea (green and black) has plausible cardiovascular, metabolic, and dementia-prevention benefits — modest, smaller than coffee's. Drink 1–3 cups/day if you enjoy it; see Tea for green-vs-black, iron interactions, and the L-theanine question.
What's overhyped
- "Wine is healthy because of resveratrol" — wine contains 0.3–1 mg resveratrol per glass; therapeutic doses in research are 100–500 mg. The cardiovascular signal in cohort data is overwhelmingly explained by lifestyle confounding, not the wine itself.
- "Bulletproof coffee" / butter coffee — calorie-dense, no demonstrated benefit over plain coffee; saturated fat content is meaningful.
- Alkaline water, "structured" water, marine-plasma / Quinton water — no clinical evidence of benefit beyond plain mineralized water; "structured" is physicochemical pseudoscience. Hydrogen water is the one functional-water exception with preliminary biology behind it. See Water.
- Daily electrolyte powders for sedentary adults — not needed below ~75 minutes of sustained exertion or heat exposure; many add substantial sugar and unnecessary sodium.